title: Clinicopathological study of expression of lymphatic vessels in renal allograft biopsy after treatment for acute rejection.
abstract: BACKGROUND
  Lymph vessel expression is related to inflammatory cell infiltration, around renal tubules in acute rejection episodes (ARE) of transplanted kidneys. However, there is little information on the lymph vessels after treatment of an ARE, particularly in relation to renal function and histological findings.
  
  
  METHODS
  We investigated 13 cases of ARE diagnosed by kidney transplant biopsy performed from 1997 to 2005 within 3 years of transplantation. Treatment of the ARE lead to an improved serum creatinine level in all cases. There was neither an ABO-incompatible nor an acute humoral rejection case. Lymphatic vessels in re-biopsies were examined using immunohistochemical staining with D2-40 antibody that detected lymphatic endothelium. Re-biopsy cases in which the baseline creatinine had increased by more than 20% despite treatment were considered the severe group; the others, as the stable group. The relation between lymphatic vessel density (LVD) and renal function was examined using Banff scores.
  
  
  RESULTS
  LVD was significantly higher in the severe than the stable group. The expression of lymph vessels versus the Banff score showed a direct relation: greater Banff scores showed higher expressions of lymph vessels.
  
  
  CONCLUSIONS
  The expression of lymph vessels in renal allograft specimens after treatment of an ARE was related to deterioration of renal function and inflammatory cell invasion. We plan a further examination of the relationship between the expression of lymph vessels and long-term prognosis.
authors.affiliation: Osaka Kaisei Hospital, 1-6-10 Miyahara, Yodogawaku, Osaka 532-0003, Japan. okaokamura@cocoa.och.ne.jp
authors.forename: K
authors.initials: K
authors.lastname: Oka
authors.forename: Y
authors.initials: Y
authors.lastname: Namba
authors.forename: N
authors.initials: N
authors.lastname: Ichimaru
authors.forename: T
authors.initials: T
authors.lastname: Moriyama
authors.forename: M
authors.initials: M
authors.lastname: Kyo
authors.forename: Y
authors.initials: Y
authors.lastname: Kokado
authors.forename: E
authors.initials: E
authors.lastname: Imai
authors.forename: S
authors.initials: S
authors.lastname: Takahara
mesh_terms: D000208:Acute Disease; D000906:Antibodies / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000276:immunology; D001706:Biopsy; D003404:Creatinine / Q000097:blood; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology*; D006801:Humans; D007074:Immunoglobulin G; D007150:Immunohistochemistry / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology*; D008208:Lymphatic System / Q000276:immunology / Q000473:pathology; D042601:Lymphatic Vessels / Q000276:immunology / Q000473:pathology*; D008297:Male; D012720:Severity of Illness Index; D014184:Transplantation, Homologous / Q000276:immunology / Q000473:pathology
chemical_list: D000906:Antibodies; D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D003404:Creatinine